GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 277 filers reported holding GW PHARMACEUTICALS PLC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $365,000 | +76.3% | 1,685 | 0.0% | 0.01% | +28.6% |
Q2 2020 | $207,000 | -37.5% | 1,685 | -41.4% | 0.01% | -36.4% |
Q3 2019 | $331,000 | -33.3% | 2,875 | 0.0% | 0.01% | -35.3% |
Q2 2019 | $496,000 | +2.3% | 2,875 | 0.0% | 0.02% | 0.0% |
Q1 2019 | $485,000 | +73.2% | 2,875 | 0.0% | 0.02% | +54.5% |
Q4 2018 | $280,000 | -21.3% | 2,875 | +39.6% | 0.01% | -8.3% |
Q3 2018 | $356,000 | – | 2,060 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 390,000 | $45,010,000 | 7.31% |
Copernicus Capital Management, LLC | 2,788 | $322,000 | 5.02% |
Integral Health Asset Management, LLC | 72,500 | $8,367,000 | 2.49% |
Parkman Healthcare Partners LLC | 81,573 | $9,414,000 | 2.41% |
AdvisorShares Investments LLC | 66,317 | $7,654,000 | 1.78% |
Tri Locum Partners LP | 40,159 | $4,635,000 | 1.68% |
ETF MANAGERS GROUP, LLC | 621,361 | $71,711,000 | 1.57% |
Redmile Group, LLC | 815,681 | $94,138,000 | 1.14% |
Redwood Investments, LLC | 108,999 | $12,580,000 | 1.07% |
ROOSEVELT INVESTMENT GROUP LLC | 127,885 | $14,759,000 | 1.05% |